Followers | 1321 |
Posts | 26906 |
Boards Moderated | 6 |
Alias Born | 12/10/2012 |
Monday, June 21, 2021 1:26:38 PM
https://inhibitortx.com/technology/suba-itraconazole/
https://www.contagionlive.com/view/fda-approves-subaitraconazole-for-treatment-of-systemic-fungal-infections
In Phase 2 testing conducted by INHIBITOR, SUBA-Itraconazole demonstrated BCC target tumor inhibition without causing the classical Hedgehog (Hh) pathway adverse events in patients with BCCNS, leading to the promise of improved tolerability and the potential to maximize efficacy enabled by continuous Hedgehog pathway inhibition to manage this genetic condition. INHIBITOR’s majority shareholder and licensing partner, Mayne Pharma, assumed further development for this indication and is currently planning the launch of global testing of SUBA-Itraconazole for treatment of BCC lesions in patients with BCCNS in 2021.
GO $INTI
Recent INTI News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 11:02:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 01:54:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 07:49:19 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 06:42:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 06:33:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 01:15:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM